unknown
Stage
About
CereGate develops a minimally invasive Computer‑Brain Interface (CBI) technology to treat neurological disorders and restore sensory and motor functions. Its approach has been clinically tested in over 85 patients to address movement, balance, and sensory impairments.
Explore CereGate's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.